Advances in Phage Therapies
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: 15 January 2025 | Viewed by 721
Special Issue Editor
Interests: phage therapy; xanthomonad; Klebsiella Pneumoniae; erwinia rhapontici
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Microorganisms invites researchers to contribute to a Special Issue dedicated to research advances in phage therapy, a promising approach to combating microbial infections.
We welcome original research, reviews, and communications covering various aspects of phage therapy. Topics of interest include phage discovery, characterization, engineering, and clinical applications. Studies elucidating phage–host interactions, viral replication, and evolution will provide insights into phage biology.
Furthermore, investigations into phage-based strategies for controlling bacterial pathogens, such as biofilm eradication, antimicrobial resistance mitigation, and targeted delivery systems, are highly encouraged. Research addressing safety, efficacy, and regulatory considerations will contribute to the translation of phage therapy into clinical practice.
By fostering interdisciplinary collaboration, this Special Issue aims to drive the development of novel phage-based therapies for personalized and targeted microbial control.
Dr. Kovács Tamás
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- phage therapies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
